Table III.
Significant Associations for Theta ERO from Case-Control GWAS and Family-Based Replication
| Stage I: GWAS |
Stage II: Replication |
||||||||
|---|---|---|---|---|---|---|---|---|---|
| SNP | Gene | Minor Allele | MAF | Effect Size (β ± SE)a | P-Value | MAF | Effect Size (β ± SE)a | P-Value | Combined P-Valueb |
| rs4907240 | ARID5A | A | 0.227 | 0.254 ± 0.055 | 3.93 × 10−6 | 0.259 | 0.104 ± 0.055 | 5.75 × 10−2 | 3.68 × 10−6 |
| rs13831 | GNAS1 | T | 0.240 | −0.209 ± 0.052 | 6.47 × 10−5 | 0.250 | −0.147 ± 0.053 | 5.95 × 10−3 | 6.07 × 10−6 |
| rs2294015 | ANXA13 | G | 0.334 | 0.211 ± 0.048 | 1.05 × 10−5 | 0.379 | 0.092 ± 0.048 | 5.84 × 10−2 | 9.39 × 10−6 |
| rs7916403 | HTR7 | T | 0.492 | 0.096 ± 0.045 | 3.20 × 10−2 | 0.474 | 0.167 ± 0.047 | 3.88 × 10−4 | 1.53 × 10−4 |
Genetic effect in the direction of minor allele.
Unadjusted P-values obtained from Fisher’s combined probability test [Fisher, 1925].